This bill amends the Code of Iowa to establish definitions and regulations concerning 340B drugs, which are covered outpatient drugs sold at reduced prices to covered entities under federal law. It introduces new definitions for "340B drug," "distributor," and "manufacturer," clarifying the roles and responsibilities of these entities in the context of drug distribution. Specifically, a "340B drug" is defined as a drug purchased by a covered entity at a reduced price, while a "distributor" is identified as any person involved in the wholesale distribution of prescription drugs, excluding manufacturers.

Furthermore, the bill imposes a prohibition on manufacturers and distributors, preventing them from denying, restricting, or interfering with the acquisition of 340B drugs by covered entities or their delivery to contract pharmacies. This restriction is applicable unless such actions are explicitly prohibited by the U.S. Department of Health and Human Services. Overall, the bill aims to protect the accessibility of 340B drugs for covered entities and ensure compliance with federal regulations.

Statutes affected:
Introduced: 510D.1, 510D.2